Rakuten Investment Management’s AstraZeneca AZN Stock Holding History

Rakuten Investment Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-15,754	Closed	-$2.92M	–	498
2025 Q4	$2.92M	Buy	15,754 +15,554	+7,777%	+$2.73M	0.01%	378
2025 Q3	$14.7K	Buy	+200	New	+$30.3K	﹤0.01%	625
2025 Q1	$1.57M	Buy	+10,636	New	+$1.54M	0.01%	429
2024 Q3	$1.03M	Buy	6,623 +1,842	+39%	+$297K	0.01%	347
2024 Q2	$747K	Buy	4,781 +1,989	+71%	+$299K	﹤0.01%	331
2024 Q1	$378K	Buy	+2,792	New	+$370K	﹤0.01%	376

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

Rakuten Investment Management's AZN Position: Q1 2026 in Review

Rakuten Investment Management sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 15,754 shares — an estimated $2.92M sold.

Rakuten Investment Management first reported a position in AZN in Q1 2024 and held it in 6 quarters. The position peaked at $2.92M in Q4 2025. 1,379 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

Rakuten Investment Management reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
Rakuten Investment Management sold 15,754 AstraZeneca shares in Q1 2026, an estimated $2.92M.
Rakuten Investment Management first reported a position in AstraZeneca in Q1 2024 and held it in 6 quarters.
Rakuten Investment Management's AstraZeneca position peaked at $2.92M in Q4 2025.
1,379 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Rakuten Investment Management's 13F filing for Q1 2026, filed 12 May 2026.